Michelstadt, Germany

Dominik Egly

This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Evonik Operations Gmbh. Active years: 2020-2021.


% Patents Active = 50.0

 

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Dominik Egly: Innovator in Dipeptide Technology

Introduction

Dominik Egly is a notable inventor based in Michelstadt, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of dipeptide-containing materials. With a total of 2 patents to his name, Egly's work is recognized for its innovative approach to producing valuable compositions.

Latest Patents

Egly's latest patents include a "Dipeptide-containing granular material" and a "Production method for dipeptide-containing granules." Both inventions relate to a process for producing a particulate composition that includes methionine, methionylmethionine, potassium in the form of potassium salt, and ammonium sulfate. These inventions highlight his expertise in creating effective and useful biochemical products.

Career Highlights

Dominik Egly is currently employed at Evonik Operations GmbH, a leading company in specialty chemicals. His role at Evonik allows him to further explore and develop innovative solutions in the field of biochemistry. His work has contributed to advancements in the production of granular materials that have various applications.

Collaborations

Egly has collaborated with esteemed colleagues such as Hans Joachim Hasselbach and Harald Jakob. These partnerships have fostered a creative environment that encourages the exchange of ideas and expertise, leading to groundbreaking innovations.

Conclusion

Dominik Egly is a prominent figure in the field of dipeptide technology, with a focus on producing valuable biochemical compositions. His contributions through patents and collaborations continue to influence advancements in the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…